Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC
Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC
Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma
Using artificial intelligence to improve lung cancer screening and risk prediction
Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC
Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma
Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours
Functional dependence predicts poorer survival in adults aged 80 and over with NSCLC
Subcutaneous tarlatamab shows promising safety and activity in previously treated extensive-stage SCLC
TELENEC reduces referral delays for childhood cancer care in Paraguay
Drone delivery could improve access to childhood cancer medicines in Ghana
Transcriptome-Wide Association Study identifies genetic factors linked to subsequent cancers in childhood cancer survivors
Adjuvant osimertinib delivers sustained long term survival benefit in EGFR mutated NSCLC